# Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients

> **NCT06916585** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shenzhen Third People's Hospital** · enrollment: 96 (estimated)

## Conditions studied

- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** AS1501 for injection

## Key facts

- **NCT ID:** NCT06916585
- **Lead sponsor:** Shenzhen Third People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916585, "Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06916585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*